Alpha 1-antichymotrypsin: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 29: | Line 29: | ||
{{protein-stub}} | {{protein-stub}} | ||
{{gene-stub}} | {{gene-stub}} | ||
{{No image}} | |||
Revision as of 05:55, 10 February 2025
Alpha 1-antichymotrypsin (also known as SERPINA3) is a protein that in humans is encoded by the SERPINA3 gene. It is a member of the serpin superfamily of proteins, which function as serine protease inhibitors. Alpha 1-antichymotrypsin is primarily produced in the liver and secreted into the bloodstream, where it plays a crucial role in the body's immune response.
Function
Alpha 1-antichymotrypsin inhibits the activity of certain enzymes, such as cathepsin G and mast cell chymase, that are released during inflammation. By doing so, it helps to limit tissue damage and promote healing. It also forms a complex with alpha-1 antitrypsin, another serpin, to inhibit the proteolytic activity of neutrophil elastase, a key enzyme involved in the body's immune response.
Clinical significance
Alterations in the SERPINA3 gene or the alpha 1-antichymotrypsin protein can lead to a variety of health conditions. For example, elevated levels of alpha 1-antichymotrypsin have been associated with Alzheimer's disease, chronic obstructive pulmonary disease (COPD), and certain types of cancer. In Alzheimer's disease, alpha 1-antichymotrypsin is found in high concentrations in the amyloid plaques that characterize the disease.
Research
Research into alpha 1-antichymotrypsin is ongoing, with scientists seeking to better understand its role in health and disease. This includes studying its potential as a biomarker for certain conditions, as well as exploring ways to target it for therapeutic purposes.
See also
References

